The High Authority for Health (HAS) recommended on Tuesday, after reassessment of vaccines, to resume vaccinating infants from six weeks to six months against rotavirus infections, the main causes of acute winter viral gastroenteritis, to prevent forms serious and hospitalizations. Two vaccines (Rotarix and RotaTeq), administered orally, have marketing authorization in France.
A vaccination is recommended with two doses at the ages of two and three months for Rotarix, with three doses at two, three and four months for RotaTeq, she specifies in a press release, inviting the use of the same vaccine for the whole scheme. vaccine. The HAS insists on respecting this schedule in order to be able to complete the vaccination schedule before the age limit (six months for Rotarix and eight months for RotaTeq). “At this stage, the HAS considers that it is premature to consider making this vaccination compulsory”she says.
Recommended by the World Health Organization, the European Academy of Pediatrics and the European Society for Pediatric Infectious Diseases, vaccination against rotavirus infections is practiced in 127 countries worldwide. Introduced in France in the vaccination calendar in 2013 by the High Council of Public Health, it was suspended in 2015 after the occurrence of serious adverse effects.